The effect of an adjunct psychosomatic intervention in patients with musculoskeletal disorders

Not Applicable

• Conditions: M54; M15-M19; M79.7; M06; Dorsalgia; Arthrosis; Fibromyalgia; Other rheumatoid arthritis

• Registration Number: DRKS00034506
• Lead Sponsor: niversitätsklinikum Regensburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Written informed consent is a prerequisite for participation.

Exclusion Criteria

Charlson-Comorbidity Index (CCI) > 3

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umeric Rating Scale for pain assessment<br>Perceived Stress Questionnaire (PSQ)<br>Quality of Life Questionnaire (EQ-5D)<br><br>The outcomes will be collected before the interventions, after four weeks, after three months and after six months.

Secondary Outcome Measures

Name	Time	Method
Consumption of pain medication<br><br>The outcomes will be collected before the interventions, after four weeks, after three months and after six months.